Patients with glaucoma treated with iDose TR experienced sustained IOP reductions, according to a press release from ...

Open-angle glaucoma is an eye disease that causes a gradual loss of vision. It is the most common type of glaucoma, a set of eye diseases that affect the eye's optic nerve. The optic nerve is ...

Accredited by the College of Optometrists, this professional qualification gives optometrists key training and skills in the detection, diagnosis and referral pathways for Chronic open angle glaucoma.

NYSE:GKOS) Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform ...

Results Cases were more likely to have coronary artery disease, chronic obstructive pulmonary ... Recently, it has been suggested that open-angle glaucoma (OAG) is associated with higher incidence ...

Corporation announced several positive clinical updates for its iDose sustained-release procedural pharmaceutical platform, ...

All participants had attended Lille University hospital for a routine clinic visit and had a mean (SD) time since diagnosis of primary open-angle glaucoma of 11.45 (6.09) years. Participants with ...

The use of bisphosphonates, particularly risedronate, in patients with osteoporosis is linked to a higher risk for acute angle closure but not open-angle glaucoma. Researchers conducted a ...